xv 459 has been researched along with dmp 728 in 1 studies
| Studies (xv 459) | Trials (xv 459) | Recent Studies (post-2010) (xv 459) | Studies (dmp 728) | Trials (dmp 728) | Recent Studies (post-2010) (dmp 728) |
|---|---|---|---|---|---|
| 15 | 2 | 0 | 26 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hantgan, RR; Mousa, SA | 1 |
1 other study(ies) available for xv 459 and dmp 728
| Article | Year |
|---|---|
Inhibition of platelet-mediated clot retraction by integrin antagonists.
Topics: Amino Acids; Antibodies, Monoclonal; Blood Platelets; Humans; Immunoglobulin Fab Fragments; Isoxazoles; Mesylates; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 1998 |